Recombinant adeno-associated viral vector, AAV2 serotype 6 (rAAv2/6), expressing human factor 8 (hf8) cDNA | |
---|---|
Trade Name | |
Orphan Indication | Hemophilia A |
USA Market Approval | USA |
USA Designation Date | 2017-05-03 00:00:00 |
Sponsor | Sangamo Therapeutics, Inc.;Point Richmond Tech Center, 501 Canal Boulevard;Richmond, California, 94804 |
Related Access Program
Joanne Kurtzberg, MD – Hypoxia Ischemia, Cerebral
Genentech, Inc. – Hemophilia A
GlaxoSmithKline – Systemic Lupus Erythematosus
Vitreous -Retina- Macula Consultants of New York – Retinal Hemangioma
Xiaofan Zhu – Hematopoiesis Maintainance.
Seoul National University Hospital – Chemical Burn
Paolo Caimi, MD – Hematopoietic/Lymphoid Cancer
Zimmer Biomet – Critical Limb Ischemia